McCaffrey targets 10 deals for MVP and Ataraxia

James McCaffrey, CEO of MVP and Ataraxia

The outbreak of the Covid-19 pandemic hit the deals pipeline at the start of March, McCaffrey, pictured, admitted, and caused a two-month pause.

However since then the firms, which will buy up to 49%

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: